Breast Neoplasm Female
Oncology
3
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Monoclonal Antibody
2100%
+ 2 programs with unclassified modality
Competitive Landscape
4 companies ranked by most advanced pipeline stage
AmgenTHOUSAND OAKS, CA
1 program1
Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]Phase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Bristol Myers SquibbNivolumab
AmgenDenosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
GenomicsARNA Breast
Clinical Trials (3)
Total enrollment: 240 patients across 3 trials
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
Start: Apr 2019Est. completion: Dec 202630 patients
Phase 2Active Not Recruiting
Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer
Start: Jul 2018Est. completion: Feb 202360 patients
Phase 1Unknown
Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer
Start: Jun 2021Est. completion: Dec 2021150 patients
N/AUnknown
Related Jobs in Oncology
Cell Therapy Account Manager(北陸)
Gilead Sciences
Japan - Tokyo
Just now
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
6h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
Florham Park, NJ
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
South San Francisco, CA
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
North Chicago, IL
8h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space